Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib.
暂无分享，去创建一个
S. Pittaluga | A. Wiestner | M. Stetler-Stevenson | A. Hamdy | I. Maric | C. Yuan | I. Ahn | E. Gaglione | M. Farooqui | Pia Nierman | C. Pleyer | Clare Sun | S. E. Herman | R. Izumi | P. Patel | J. Cheung | Ellen K. Kendall | T. Covey | M. Wang | Michael Gulrajani | Hailey M. Harris | Jean P. Cheung